Business ❯Competition

Pharmaceutical Industry

Novo Nordisk Novo Nordisk vs. Eli Lilly Moderna vs Pfizer Eli Lilly Market Trends Biogen COVID-19 Vaccines

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

The experimental drug combines GLP-1 and amylin hormones, offering potential advances in obesity treatment.

Eli Lilly Invests $1.8 Billion to Expand Drug Production in Ireland

Moderna Lowers Annual Sales Forecast Amid Competitive Vaccine Market

FDA Approves Moderna's mRNA RSV Vaccine for Older Adults

FDA Delays Approval of Eli Lilly's Alzheimer's Drug Donanemab

Novo Nordisk Expands Production Capacity with $16.5 Billion Catalent Acquisition